Eurasian Hematology-Oncology Group

http://www.ehog.net/

 

55 views
February 16, 2024

Chapters

Comparing Monotherapy & Combinations in CLL

00:00

Progression-Free Survival in CLL Treatment Trials

05:27

Monotherapy Outcomes in CLL with TP53 Mutations

08:58

Considering BTK Inhibitor Toxicities in Treatment Choice

10:23

Comments 0
Login to view comments. Click here to Login